HWAM
UTHR icon

Hennion & Walsh Asset Management’s United Therapeutics UTHR Stock Holding History

Hennion & Walsh Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.3M Sell
6,097
-98
-2% -$55.2K 0.09% 270
2026
Q1 		$3.67M Sell
6,195
-59
-0.9% -$29.4K 0.12% 211
2025
Q4 		$3.05M Sell
6,254
-120
-2% -$55.9K 0.11% 250
2025
Q3 		$2.67M Buy
6,374
+935
+17% +$314K 0.1% 273
2025
Q2 		$1.56M Buy
5,439
+1,142
+27% +$341K 0.06% 366
2025
Q1 		$1.32M Buy
4,297
+1,970
+85% +$675K 0.06% 401
2024
Q4 		$821K Sell
2,327
-1,959
-46% -$720K 0.04% 511
2024
Q3 		$1.54M Buy
4,286
+1,023
+31% +$346K 0.07% 352
2024
Q2 		$1.04M Sell
3,263
-28
-0.9% -$7.41K 0.05% 412
2024
Q1 		$756K Buy
3,291
+413
+14% +$93.2K 0.04% 483
2023
Q4 		$633K Sell
2,878
-41
-1% -$9.45K 0.04% 514
2023
Q3 		$659K Buy
2,919
+210
+8% +$48.4K 0.04% 452
2023
Q2 		$598K Buy
2,709
+55
+2% +$12.2K 0.04% 466
2023
Q1 		$594K Sell
2,654
-2,488
-48% -$613K 0.04% 473
2022
Q4 		$1.43M Sell
5,142
-14,314
-74% -$3.61M 0.09% 265
2022
Q3 		$4.07M Sell
19,456
-1,265
-6% -$283K 0.27% 91
2022
Q2 		$4.88M Sell
20,721
-17,372
-46% -$3.53M 0.3% 78
2022
Q1 		$6.83M Sell
38,093
-1,467
-4% -$279K 0.36% 64
2021
Q4 		$8.55M Sell
39,560
-2,910
-7% -$571K 0.42% 53
2021
Q3 		$7.84M Sell
42,470
-598
-1% -$118K 0.41% 54
2021
Q2 		$7.73M Buy
43,068
+4,996
+13% +$952K 0.41% 50
2021
Q1 		$6.37M Buy
+38,072
New +$6.35M 0.38% 63

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Hennion & Walsh Asset Management's UTHR Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its United Therapeutics (UTHR) stake by 1.6% in Q2 2026, selling an estimated $55.2K and leaving 6,097 shares worth $3.3M. The position accounts for 0.09% of the portfolio, ranked #270.

Hennion & Walsh Asset Management first reported a position in UTHR in Q1 2021 and has held it in 22 quarters since. The position peaked at $8.55M in Q4 2021. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Hennion & Walsh Asset Management held 6,097 shares of United Therapeutics worth $3.3M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 98 United Therapeutics shares in Q2 2026, an estimated $55.2K.
  • United Therapeutics made up 0.09% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #270 holding.
  • Hennion & Walsh Asset Management first reported a position in United Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Hennion & Walsh Asset Management's United Therapeutics position peaked at $8.55M in Q4 2021.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.